The TSHR is a target autoantigen in Graves’ disease (GD) [4–6], where TSHR autoantibodies (TRAbs) induce thyroid growth and hyperthyroidism and represent an important diagnostic hallmark. This evidence concerns the gene TSHR and hyperthyroidism.